Case number 1:23-cv-00410
Bayer Pharma AG et al v. Dr. Reddy's Laboratories, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 8, 2024 | 15 | Joint Status Report Regarding Stay, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/11/2024 (nms). (Entered: 03/08/2024) (5) |
| Sep 8, 2023 | 13 | STIPULATION and [Proposed] Order Regarding Stay - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/08/2023) (4) |
| Sep 8, 2023 | 14 | SO ORDERED Granting (D.I. 13 in 23-cv-410-RGA; D.I. 186 in 21-md-3017-RGA; D.I. 126 in 21-cv-1742-RGA; D.I. 152 in 21-cv-314-RGA-JLH) Stipulation and Proposed Order Regarding Stay. Signed by Judge Richard G. Andrews on 9/8/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:23-cv-00410-RGA(nms) (Entered: 09/08/2023) (4) |
| Aug 15, 2023 | 10 | ANSWER to 1 Complaint, with Separate Defenses, by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Belgam, Neal) Modified on 8/15/2023 (nms). (Entered: 08/15/2023) (17) |
| Aug 15, 2023 | 11 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories Ltd. for Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Belgam, Neal) (Entered: 08/15/2023) (1) |
| Aug 15, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein and Kiersten A. Fowler - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Belgam, Neal) (Entered: 08/15/2023) (4) |
| May 17, 2023 | 8 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Dr. Reddy's Laboratories Inc. waiver sent on 5/16/2023, answer due 8/14/2023. (Fahnestock, Derek) (Entered: 05/17/2023) (1) |
| May 17, 2023 | 9 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Dr. Reddy's Laboratories Ltd. waiver sent on 5/16/2023, answer due 8/14/2023. (Fahnestock, Derek) (Entered: 05/17/2023) (1) |
| Apr 19, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 04/19/2023) (0) |
| Apr 13, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (Filing fee $ 402, receipt number ADEDC-4112327.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Main Document 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Main Document) (13) |
| Apr 13, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 04/13/2023) (3) |
| Apr 13, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/16/23. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: Not Applicable. (jfm) (Entered: 04/13/2023) (1) |
| Apr 13, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (jfm) (Entered: 04/13/2023) (1) |
| Apr 13, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (jfm) (Entered: 04/13/2023) (1) |
| Apr 13, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (jfm) (Entered: 04/13/2023) (1) |
| Apr 13, 2023 | 7 | Summons Issued as to Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. on 4/13/2023. (Attachments: # 1 Summons Issued Dr. Reddy's Laboratories, Ltd.)(jfm) (Main Document 7 replaced on 4/14/2023) (jfm). (Attachment 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Main Document) (2) |
| Apr 13, 2023 | N/A | Remark: MDL panel has been advised. (jfm) (Entered: 04/14/2023) (0) |
| Apr 13, 2023 | 7 | Summons Issued as to Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. on 4/13/2023. (Attachments: # 1 Summons Issued Dr. Reddy's Laboratories, Ltd.)(jfm) (Main Document 7 replaced on 4/14/2023) (jfm). (Attachment 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Summons Issued Dr. Reddy's Laboratories, Ltd.) (2) |
| Apr 13, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (Filing fee $ 402, receipt number ADEDC-4112327.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Main Document 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Exhibit A) (27) |
| Apr 13, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (Filing fee $ 402, receipt number ADEDC-4112327.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Main Document 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Civil Cover Sheet) (2) |
